PhAzE chemistry uses cell-permeable phospho-triazole reagents to covalently bond tyrosine and lysine residues in proteins, mimicking natural phosphorylation with low toxicity and tunable reactivity, enabling chiral probe design and potential RNA targeting.
Background
Covalent chemistry has become a cornerstone of modern chemical biology and drug discovery, enabling selective modification of protein side chains to probe function and regulate activity in complex biological systems. As interest grows in mapping post-translational modifications and developing targeted covalent inhibitors, researchers require cell-permeable, residue-specific reagents that can operate under physiological conditions with minimal toxicity. In particular, there is a pressing need for tools capable of mimicking phosphorylation-like adducts and expanding beyond the traditional focus on cysteine residues, thereby opening new avenues for studying kinases, phosphatases, and signaling networks in live cells and tissues.
Existing electrophilic probes often suffer from narrow residue scope, off-target reactivity and safety concerns. Fluorophosphonates, for example, primarily target active-site serines but exhibit significant toxicity and irreversible inhibition of essential enzymes such as acetylcholinesterase. Sulfur-fluoride exchange (SuFEx) and sulfur-triazole exchange (SuTEx) chemistries address some limitations but lack tunable kinetics, inherent chirality for enantioselectivity and broad amino-acid coverage. Moreover, many current approaches cannot faithfully mimic natural phosphoryl modifications or allow fine-tuning of reactivity, leading to poor selectivity, high background labeling and limited applicability in live-cell profiling.
Technology Description
Phosphorous-azole exchange (PhAzE) chemistry leverages phospho-triazole electrophiles in which a phosphorus center embedded within a six-membered heterocycle bearing a triazole leaving group reacts with nucleophilic side chains in proteins to form stable phosphorus–amino acid adducts that mimic natural phosphorylation. These cell-permeable reagents exhibit minimal toxicity at concentrations up to 100 μM and preferentially modify tyrosine and lysine residues, in contrast to fluorophosphonates that target serine. The inherent chirality of the phosphorus center supports the design of enantioselective probes, while reactivity rates can be finely tuned by altering substituents on phosphorus to modulate steric hindrance. Activity-based protein profiling coupled with LC–MS/MS has confirmed target engagement and suggests potential expansion of this chemistry to other biomolecules such as RNA.
This technology is differentiated by its reduced off-target toxicity and unique residue selectivity. Unlike traditional fluorophosphonates, it avoids significant acetylcholinesterase inhibition and does not require cysteine nucleophiles, expanding the covalent targeting toolkit to include tyrosines and lysines. The tunable electrophilicity enabled by modular substituents allows optimization for specific biological contexts, while inherent chirality opens avenues for enantioselective binding and probe development. Together, these features position PhAzE chemistry as a versatile platform for covalent probe and therapeutic development, with future applications in live-cell proteomics, synthetic organic chemistry, and RNA-targeted modifications.
Benefits
- Reduced toxicity compared to fluorophosphonates, with minimal toxicity up to 100 µM
- Selective targeting of tyrosine and lysine residues, expanding the range of modifiable amino acids
- Cell-permeability enabling live-cell and in vivo applications
- Tunable reactivity via phosphorous substituents to optimize steric and electronic properties
- Inherent chirality supports the design of enantioselective probes
- Confirmed target engagement through activity-based protein profiling and LC–MS/MS
- Potential applicability to other biomolecules such as RNA
Commercial Applications
- Phospho-mimetic probes
- Covalent drug development
- Proteomic profiling reagents
- Chiral electrophile synthesis kits
- RNA-targeted chemical probes
Additional Information
A method employing phosphorous-centered six-membered rings bearing triazole leaving groups that react with nucleophilic protein side chains to form stable phosphorous–amino acid adducts, mimicking phosphorylation. These cell-permeable electrophiles exhibit low toxicity up to 100 µM, selectively target tyrosine and lysine, and feature tunable reactivity and chirality, enabling enantioselective probe design; target engagement validated by activity-based protein profiling with LC–MS/MS.
PCT Patent filed 5/12/25 PCT/US2025/028985
